Research progress on Chinese materia medica inhibitors with anti-human respiratory syncytial virus effect
10.7501/j.issn.0253-2670.2017.17.031
- Author:
Meng-Di ZHANG
1
Author Information
1. College of Pharmacy, Shandong University of Traditional Chinese Medicine
- Publication Type:Journal Article
- Keywords:
Chinese materia medica;
Chinese materia medica compound;
Human respiratory syncytial virus;
New drug development;
Respiratory tract infections
- From:
Chinese Traditional and Herbal Drugs
2017;48(17):3650-3653
- CountryChina
- Language:Chinese
-
Abstract:
Human respiratory syncytial virus (hRSV) was considered to be the leading cause of lower respiratory tract disease in infants and young children. So far, there was a lack of effective anti-hRSV drugs and vaccines. In this paper, the latest research progress on anti hRSV infection drugs was reviewed from three aspects of effective constituents of Chinese materia medica, Chinese materia medica, and Chinese medicine compound antiviral inhibitor research and development, which would lay a theoretical foundation for the research and development of anti-hRSV drugs and the anti hRSV infection treatment strategy.
